These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16856007)

  • 21. Erythropoietin, uncertainty principle and cancer related anaemia.
    Clark O; Adams JR; Bennett CL; Djulbegovic B
    BMC Cancer; 2002 Sep; 2():23. PubMed ID: 12270068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.
    Waltzman R; Croot C; Justice GR; Fesen MR; Charu V; Williams D
    Oncologist; 2005 Sep; 10(8):642-50. PubMed ID: 16177289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of weekly darbepoetin alfa in the treatment of anaemia of HIV-infected haemodialysis patients.
    Lucas C; Carrera F; Jorge C; Boquinhas H; Pais MJ
    Nephrol Dial Transplant; 2006 Nov; 21(11):3202-6. PubMed ID: 16891651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment for women with postpartum iron deficiency anaemia.
    Dodd J; Dare MR; Middleton P
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004222. PubMed ID: 15495089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
    Reed SD; Radeva JI; Daniel DB; Mody SH; Forlenza JB; McKenzie RS; Schulman KA
    Pharmacoeconomics; 2006; 24(5):479-94. PubMed ID: 16706573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline.
    Vansteenkiste J; Tomita D; Rossi G; Pirker R
    Support Care Cancer; 2004 Apr; 12(4):253-62. PubMed ID: 14740283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003].
    Spaeth D; Casadevall N; Daouphars M; Marchal C; Marec-Berard P; Fabre N; Haugh M;
    Bull Cancer; 2004 Feb; 91(2):179-88. PubMed ID: 15047458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
    Quirt I; Micucci S; Moran LA; Pater J; Browman G
    Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
    Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
    Bennett CL; Silver SM; Djulbegovic B; Samaras AT; Blau CA; Gleason KJ; Barnato SE; Elverman KM; Courtney DM; McKoy JM; Edwards BJ; Tigue CC; Raisch DW; Yarnold PR; Dorr DA; Kuzel TM; Tallman MS; Trifilio SM; West DP; Lai SY; Henke M
    JAMA; 2008 Feb; 299(8):914-24. PubMed ID: 18314434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
    Henry DH
    Drugs; 2007; 67(2):175-94. PubMed ID: 17284083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Darbepoetin alfa: in patients with chemotherapy-related anaemia.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(11):1067-74; discussion 1075-7. PubMed ID: 12749734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial.
    Urena M; Del Trigo M; Altisent OA; Campelo-Prada F; Regueiro A; DeLarochellière R; Doyle D; Mohammadi S; Paradis JM; Dagenais F; Dumont E; Puri R; Laroche V; Rodés-Cabau J
    EuroIntervention; 2017 May; 13(1):44-52. PubMed ID: 28067195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventions for erythropoietin-resistant anaemia in dialysis patients.
    Badve SV; Beller EM; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006861. PubMed ID: 23979995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.
    Seidenfeld J; Piper M; Flamm C; Hasselblad V; Armitage JO; Bennett CL; Gordon MS; Lichtin AE; Wade JL; Woolf S; Aronson N
    J Natl Cancer Inst; 2001 Aug; 93(16):1204-14. PubMed ID: 11504766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
    Zarychanski R; Turgeon AF; McIntyre L; Fergusson DA
    CMAJ; 2007 Sep; 177(7):725-34. PubMed ID: 17823140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy of anaemia in cancer patients.
    Mercadante S
    Expert Opin Pharmacother; 2001 Dec; 2(12):1949-61. PubMed ID: 11825327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review.
    Lin DM; Lin ES; Tran MH
    Transfus Med Rev; 2013 Oct; 27(4):221-34. PubMed ID: 24135037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003].
    Marchal C; Spaeth D; Casadevall N; Daouphars M; Marec-Berard P; Fabre N; Haugh M;
    Cancer Radiother; 2004 Jun; 8(3):197-206. PubMed ID: 15260007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of chemotherapy-induced anaemia.
    Vansteenkiste J
    Expert Opin Pharmacother; 2003 Dec; 4(12):2221-7. PubMed ID: 14640921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.